2025-01-01 2025-12-31 2025-12-31 false 15475459 AISTHESIS MEDICAL LIMITED 2026-03-18 72110 false iso4217:GBP xbrli:pure 15475459 2024-12-31 15475459 2025-12-31 15475459 2025-01-01 2025-12-31 15475459 2024-02-08 15475459 2024-12-31 15475459 2024-02-09 2024-12-31 15475459 bus:SmallEntities 2025-01-01 2025-12-31 15475459 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 15475459 bus:FullAccounts 2025-01-01 2025-12-31 15475459 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15475459 core:WithinOneYear 2025-12-31 15475459 core:AfterOneYear 2025-12-31 15475459 core:WithinOneYear 2024-12-31 15475459 core:AfterOneYear 2024-12-31 15475459 core:ShareCapital 2025-12-31 15475459 core:SharePremium 2025-12-31 15475459 core:RevaluationReserve 2025-12-31 15475459 core:OtherReservesSubtotal 2025-12-31 15475459 core:RetainedEarningsAccumulatedLosses 2025-12-31 15475459 core:ShareCapital 2024-12-31 15475459 core:SharePremium 2024-12-31 15475459 core:RevaluationReserve 2024-12-31 15475459 core:OtherReservesSubtotal 2024-12-31 15475459 core:RetainedEarningsAccumulatedLosses 2024-12-31 15475459 core:LandBuildings 2025-12-31 15475459 core:PlantMachinery 2025-12-31 15475459 core:Vehicles 2025-12-31 15475459 core:FurnitureFittings 2025-12-31 15475459 core:OfficeEquipment 2025-12-31 15475459 core:NetGoodwill 2025-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 15475459 core:ListedExchangeTraded 2025-12-31 15475459 core:UnlistedNon-exchangeTraded 2025-12-31 15475459 core:LandBuildings 2024-12-31 15475459 core:PlantMachinery 2024-12-31 15475459 core:Vehicles 2024-12-31 15475459 core:FurnitureFittings 2024-12-31 15475459 core:OfficeEquipment 2024-12-31 15475459 core:NetGoodwill 2024-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 15475459 core:ListedExchangeTraded 2024-12-31 15475459 core:UnlistedNon-exchangeTraded 2024-12-31 15475459 core:LandBuildings 2025-01-01 2025-12-31 15475459 core:PlantMachinery 2025-01-01 2025-12-31 15475459 core:Vehicles 2025-01-01 2025-12-31 15475459 core:FurnitureFittings 2025-01-01 2025-12-31 15475459 core:OfficeEquipment 2025-01-01 2025-12-31 15475459 core:NetGoodwill 2025-01-01 2025-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 15475459 core:ListedExchangeTraded 2025-01-01 2025-12-31 15475459 core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 15475459 core:MoreThanFiveYears 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments 2025-12-31 15475459 core:Non-currentFinancialInstruments 2024-12-31 15475459 dpl:CostSales 2025-01-01 2025-12-31 15475459 dpl:DistributionCosts 2025-01-01 2025-12-31 15475459 core:LandBuildings 2025-01-01 2025-12-31 15475459 core:PlantMachinery 2025-01-01 2025-12-31 15475459 core:Vehicles 2025-01-01 2025-12-31 15475459 core:FurnitureFittings 2025-01-01 2025-12-31 15475459 core:OfficeEquipment 2025-01-01 2025-12-31 15475459 dpl:AdministrativeExpenses 2025-01-01 2025-12-31 15475459 core:NetGoodwill 2025-01-01 2025-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 15475459 dpl:GroupUndertakings 2025-01-01 2025-12-31 15475459 dpl:ParticipatingInterests 2025-01-01 2025-12-31 15475459 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-01 2025-12-31 15475459 core:ListedExchangeTraded 2025-01-01 2025-12-31 15475459 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 15475459 core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 15475459 dpl:CostSales 2024-02-09 2024-12-31 15475459 dpl:DistributionCosts 2024-02-09 2024-12-31 15475459 core:LandBuildings 2024-02-09 2024-12-31 15475459 core:PlantMachinery 2024-02-09 2024-12-31 15475459 core:Vehicles 2024-02-09 2024-12-31 15475459 core:FurnitureFittings 2024-02-09 2024-12-31 15475459 core:OfficeEquipment 2024-02-09 2024-12-31 15475459 dpl:AdministrativeExpenses 2024-02-09 2024-12-31 15475459 core:NetGoodwill 2024-02-09 2024-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2024-02-09 2024-12-31 15475459 dpl:GroupUndertakings 2024-02-09 2024-12-31 15475459 dpl:ParticipatingInterests 2024-02-09 2024-12-31 15475459 dpl:GroupUndertakings core:ListedExchangeTraded 2024-02-09 2024-12-31 15475459 core:ListedExchangeTraded 2024-02-09 2024-12-31 15475459 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-02-09 2024-12-31 15475459 core:UnlistedNon-exchangeTraded 2024-02-09 2024-12-31 15475459 core:NetGoodwill 2025-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 15475459 core:LandBuildings 2025-12-31 15475459 core:PlantMachinery 2025-12-31 15475459 core:Vehicles 2025-12-31 15475459 core:FurnitureFittings 2025-12-31 15475459 core:OfficeEquipment 2025-12-31 15475459 core:AfterOneYear 2025-12-31 15475459 core:WithinOneYear 2025-12-31 15475459 core:ListedExchangeTraded 2025-12-31 15475459 core:UnlistedNon-exchangeTraded 2025-12-31 15475459 core:ShareCapital 2025-12-31 15475459 core:SharePremium 2025-12-31 15475459 core:RevaluationReserve 2025-12-31 15475459 core:OtherReservesSubtotal 2025-12-31 15475459 core:RetainedEarningsAccumulatedLosses 2025-12-31 15475459 core:NetGoodwill 2024-12-31 15475459 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 15475459 core:LandBuildings 2024-12-31 15475459 core:PlantMachinery 2024-12-31 15475459 core:Vehicles 2024-12-31 15475459 core:FurnitureFittings 2024-12-31 15475459 core:OfficeEquipment 2024-12-31 15475459 core:AfterOneYear 2024-12-31 15475459 core:WithinOneYear 2024-12-31 15475459 core:ListedExchangeTraded 2024-12-31 15475459 core:UnlistedNon-exchangeTraded 2024-12-31 15475459 core:ShareCapital 2024-12-31 15475459 core:SharePremium 2024-12-31 15475459 core:RevaluationReserve 2024-12-31 15475459 core:OtherReservesSubtotal 2024-12-31 15475459 core:RetainedEarningsAccumulatedLosses 2024-12-31 15475459 core:NetGoodwill 2024-02-08 15475459 core:IntangibleAssetsOtherThanGoodwill 2024-02-08 15475459 core:LandBuildings 2024-02-08 15475459 core:PlantMachinery 2024-02-08 15475459 core:Vehicles 2024-02-08 15475459 core:FurnitureFittings 2024-02-08 15475459 core:OfficeEquipment 2024-02-08 15475459 core:AfterOneYear 2024-02-08 15475459 core:WithinOneYear 2024-02-08 15475459 core:ListedExchangeTraded 2024-02-08 15475459 core:UnlistedNon-exchangeTraded 2024-02-08 15475459 core:ShareCapital 2024-02-08 15475459 core:SharePremium 2024-02-08 15475459 core:RevaluationReserve 2024-02-08 15475459 core:OtherReservesSubtotal 2024-02-08 15475459 core:RetainedEarningsAccumulatedLosses 2024-02-08 15475459 core:AfterOneYear 2025-01-01 2025-12-31 15475459 core:WithinOneYear 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:CostValuation 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 15475459 core:Non-currentFinancialInstruments core:CostValuation 2025-12-31 15475459 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-12-31 15475459 core:Non-currentFinancialInstruments core:CostValuation 2024-12-31 15475459 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-12-31 15475459 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-12-31 15475459 bus:Director1 2025-01-01 2025-12-31 15475459 bus:Director2 2025-01-01 2025-12-31 15475459 bus:Director3 2025-01-01 2025-12-31 15475459 bus:Director4 2025-01-01 2025-12-31

AISTHESIS MEDICAL LIMITED

Registered Number
15475459
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

AISTHESIS MEDICAL LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors | Vasileios Dimakopoulos
| Ioannis Gkouzionis
| Sotirios Liliopoulos
| Iain Miller

Registered Address | 1 Royal Street
| London
| SE1 7LL

Registered Number | 15475459 (England and Wales)

AISTHESIS MEDICAL LIMITED
Balance Sheet as at
31 December 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 3,017 |  |  |  | -
Investments | 4 |  |  | 4,515 |  |  |  | -
|  |  |  | 7,532 |  |  |  | -
Current assets |  |  |  |  |  |  |  |
Debtors | 5 | 2,845 |  |  |  | 1 |  |
Cash at bank and on hand |  | 541,202 |  |  |  | 477 |  |
|  | 544,047 |  |  |  | 478 |  |
Creditors amounts falling due within one year | 6 | (15,255) |  |  |  | (2,257) |  |
Net current assets (liabilities) |  |  |  | 528,792 |  |  |  | (1,779)
Total assets less current liabilities |  |  |  | 536,324 |  |  |  | (1,779)
Net assets |  |  |  | 536,324 |  |  |  | (1,779)
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1,345 |  |  |  | 900
Share premium |  |  |  | 899,683 |  |  |  | -
Profit and loss account |  |  |  | (364,704) |  |  |  | (2,679)
Shareholders' funds |  |  |  | 536,324 |  |  |  | (1,779)

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 18 March 2026, and are signed on its behalf by:
Ioannis Gkouzionis Director Registered Company No. 15475459

AISTHESIS MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%)
| Office Equipment | 25

| Investments
--- | ---
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 3 |  | 0

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 3,218 |  | 3,218
| At 31 December 25 | 3,218 |  | 3,218
| Depreciation and impairment
| Charge for year | 201 |  | 201
| At 31 December 25 | 201 |  | 201
| Net book value
| At 31 December 25 | 3,017 |  | 3,017
| At 31 December 24 | - |  | -

4. | Fixed asset investments
--- | ---

|  | Other investments1 |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 4,515 |  | 4,515
| At 31 December 25 | 4,515 |  | 4,515
| Net book value
| At 31 December 25 | 4,515 |  | 4,515
| At 31 December 24 | - |  | -

| Notes
--- | ---
| 1Other investments other than loans

5. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | 2,845 |  | 1
| Total | 2,845 |  | 1

6. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 6,435 |  | -
| Other creditors | 8,820 |  | -
| Accrued liabilities and deferred income | - |  | 2,257
| Total | 15,255 |  | 2,257

7. | Contingent liabilities
--- | ---
| There were no financial guarantees or commitments, either ongoing or entered into during the period.

8. | Directors advances, credits and guarantees
--- | ---
| There were no advances, credits and guarantees granted to the directors during the period.

9. | Off-balance sheet arrangements
--- | ---
| The company had no off-balance sheet arrangements at year-end or at any stage during the period.